Abstract
We met a 61-year-old woman who had been suffering from dyspnea due to pleuritis carcinomatosa derived from recurrent breast cancer for which no former chemotherapy had been effective. Capecitabine mono-therapy could exert a drastic anticancer effect for lymphangiosis carcinomatosa causing more severe symptoms of dyspnea. This therapeutic option could be selected for patients with recurrent breast cancer for which the first- or second-line chemotherapy could not provide a sufficient anti-cancer efficacy and possibly serve to sustain the life quality of the patients.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Administration, Oral
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Breast Neoplasms / complications
-
Breast Neoplasms / drug therapy*
-
Capecitabine
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / analogs & derivatives*
-
Fluorouracil / therapeutic use
-
Humans
-
Lymphangitis / drug therapy*
-
Lymphangitis / etiology
-
Middle Aged
-
Pleurisy / drug therapy
-
Pleurisy / etiology
-
Quality of Life
-
Recurrence
-
Tomography, X-Ray Computed
Substances
-
Antimetabolites, Antineoplastic
-
Deoxycytidine
-
Capecitabine
-
Fluorouracil